Published on 22/12/2025
ATMP GMP Inspection Readiness Evidence Pack in 2025 – Playbook 8
Step 1: Understanding the Regulatory Framework for ATMPs
Advanced Therapy Medicinal Products (ATMPs) are governed by a complex landscape of regulations to ensure they meet the safety, efficacy, and quality standards required for market approval. This step outlines the key regulatory frameworks relevant to ATMP GMP (Good Manufacturing Practice) and will provide foundational knowledge for subsequent steps in the inspection readiness process.
ATMPs encompass gene therapies, somatic cell therapies, and tissue-engineered products. In the United States, these products are primarily regulated under the Federal Food, Drug, and Cosmetic Act (FDCA) and must comply with the FDA’s 21 CFR Parts 210 and 211 for drug manufacturing, as well as additional guidance specific to ATMPs. An important resource is the FDA’s guidance document on gene therapy, which outlines critical considerations during development and manufacturing.
It’s essential to understand the
Additionally, ensure compliance with Annex 1 to the EU GMP Guidelines, which provides detailed information on manufacturing sterile medicinal products—a crucial aspect when working with ATMPs. Maintaining a thorough understanding of these regulatory frameworks will prepare you for inspection readiness.
Step 2: Preparing Your Quality System Documentation
The quality system documentation serves as the backbone of your GMP compliance efforts. This documentation should encompass a comprehensive set of policies, procedures, and records that clearly delineate how your ATMP manufacturing processes adhere to regulatory requirements. The first action in this preparation phase is to establish the quality management system (QMS).
Your QMS should align with ISO 13485 for medical devices, ensuring that the necessary controls are in place for design input, process control, and traceability throughout the manufacturing life cycle. Develop and document standard operating procedures (SOPs) that apply to all immediate GMP activities, such as production, testing, release, and distribution. These SOPs should be regularly reviewed and updated to reflect current practices and regulatory requirements.
Ensure that your batch records are comprehensive, which detail the entire manufacturing process, including raw material specifications, production parameters, test results, and batch reconciliation. Each batch record should support traceability and accountability throughout the manufacturing process, demonstrating that each product meets predefined specifications. Pay particular attention to the requirements laid out in Annex 2, as it provides guidelines for the manufacture of ATMPs.
Regularly perform internal audits of your QMS and documentation to identify potential gaps before an official inspection occurs. Utilize a checklist approach to cover all critical areas including training records, equipment maintenance logs, environmental monitoring, and change control procedures.
This stage is critical as auditors will focus on the robustness of your quality documentation during their assessment. Creating a culture of compliance and thorough documentation will enhance your readiness significantly.
Step 3: Ensuring Cleanroom Environment Compliance
Cleanrooms are vital for ATMP manufacturing, as these controlled environments significantly reduce contamination risk, ensuring product quality. Compliance with cleanroom regulations directly impacts the success of your GMP inspection process. Start with assessing your cleanroom’s classification according to the European Standard EN 14644, which categorizes cleanrooms based on particulate contamination levels.
Identify the necessary cleanroom classification suitable for your ATMP operations. Most ATMPs require a cleanroom classified at least as ISO Class 7 or 8, particularly during the filling and packaging processes. Steps for compliance include following proper airflow patterns, ensuring that all surfaces are non-porous, and establishing a strict cleaning regimen.
Document microbiological monitoring within your cleanroom, establishing a regular schedule for air and surface sampling. The results should be logged and analyzed to verify the effectiveness of cleaning procedures and air filtration systems. Review these findings in your quality documentation as they are crucial for demonstrating compliance during inspections.
Training of personnel on cleanroom protocols cannot be overlooked. All employees working within cleanroom environments should undergo regular training in gowning, contamination control, and emergency procedures. Maintain records of training sessions and ensure that refresher courses are scheduled to educate teams continuously regarding the importance of maintaining a sterile environment.
Finally, consider conducting simulated inspections internally to assess your cleanroom operations. Create scenarios that auditors may present and assess how your team responds, ensuring they are well-prepared for any queries or challenges that may arise regarding cleanroom compliance.
Step 4: Engaging Qualified Persons (QPs)
One of the key components of GMP compliance in ATMP manufacturing is the involvement of qualified persons (QPs). A QP is responsible for ensuring that each batch of ATMP has been manufactured in accordance with GMP and that appropriate quality checks have been performed before the product is released onto the market. Begin by ensuring that your organization hires or contracts individuals who meet the requisite qualifications and training as outlined by regulatory bodies.
Your QPs should possess comprehensive knowledge of the specific ACT guidelines and regulatory expectations concerning ATMP manufacturing. As the person accountable for ensuring compliance, they act as a primary point of contact during inspections, thus playing a vital role in your inspection readiness.
Ensure that the QP’s responsibilities are clearly defined in your quality documentation. They should be actively involved in important procedures such as reviewing batch records prior to release, monitoring compliance within cleanroom operations, and participating in internal audits. Their insights and findings should be well-documented and followed up with appropriate corrective actions.
Regular training opportunities should be provided for QPs to remain up-to-date with changes in industry regulations and best practices. Active participation in relevant workshops or professional organizations will enhance their capabilities and keep your organization aligned with industry standards.
Documentation of QP activities, including batch releases and deviations, is essential. A robust record-keeping system ensures that any decisions made by the QP regarding batch release are fully traceable, showcasing compliance to external inspectors.
Step 5: Conducting Comprehensive Pre-Inspection Readiness Assessments
The final step in achieving ATMP GMP inspection readiness involves conducting a thorough pre-inspection assessment. This process should begin well in advance of any regulator-initiated inspections and incorporate lessons learned from previous audits or inspections.
Develop a checklist tailored to the specific requirements of your ATMP products and manufacturing processes. This checklist should include all essential elements from your QMS, cleanroom protocols, personnel training documentation, and QP involvement. A comprehensive review of these elements will identify discrepancies or areas needing improvement before an official inspection occurs.
Organize mock inspections with key stakeholders to create realistic pre-inspection scenarios. Engage cross-functional teams including Quality Assurance, Regulatory Affairs, and Production, allowing them to practice answering potential auditor questions and demonstrate their knowledge of processes and documentation.
Additionally, gather feedback on the outcomes from mock inspections and address any deficiencies immediately. This iterative process establishes a culture of continuous improvement, thereby enhancing both readiness and performance.
EngAGE senior leadership in these preparations by conducting reviews of the inspection readiness assessments and ensure that there is a shared understanding of compliance expectations across all levels of the organization.
Ultimately, achieving ATMP GMP inspection readiness is an ongoing collaborative effort that utilizes structured, systematic approaches to compliance. Regular reviews of your practices in line with the relevant regulations, ensuring comprehensive documentation, and conducting regular training will secure your institution’s preparedness for any regulatory inspection.